Sources: FactSet, Tullett Prebon, Currencies: Currency quotes are updated in real-time. The urgency to develop a vaccine may lift all companies involved in such projects. Industry, sector and description for Moderna INC. 3 Things About Coronavirus Vaccines That You Almost Certainly Won't Like, Forget Moderna -- This Is A More Lucrative Coronavirus Stock, These 2 Robinhood Favorites Could Double by 2022, 3 Reasons to Buy Moderna and 1 Reason to Sell, Moderna INC (MRNA) Q3 2020 Earnings Call Transcript, Moderna Expects First Look at Coronavirus Vaccine Candidate Data in November, Why Coronavirus Vaccine Stocks Moderna, Novavax, and Inovio Are Sinking Today. The overall stock market sell-off is pulling all three biotech stocks down. It is essential to note that these moves are in line with the broader market moves. Factset: FactSet Research Systems Inc.2019. GBP/USD is trading around 1.29, under pressure. NASDAQ: Moderna dropped sharply on Friday, falling by over 5% to close at $67.47. balance sheet and inputs from the stock market. MRNA earnings call for the period ending June 30, 2019. MRNA earnings call for the period ending September 30, 2020. The most significant competition comes from the UK – the University of Oxford and AstraZeneca are also engaged in Phase 3 testing and have recently announced that they are accelerating their efforts to approve a vaccine. Revenue) or per share (e.g. All rights reserved. Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, and premium investing services. Moderna Stock Will Jump in Value On Completing Covid-19 ... *Price and Yield of the Respective ... Moderna, Inc. engages in the development of … Those early results could show that mRNA-1273 is effective enough against COVID-19 -- but if not, it will have several shots to hit its goal. EUR/USD remains pressured under 1.1650 after the US ISM Manufacturing PMI beat estimates with 59.3 points. The high price target for MRNA is $134.00 and the low price target for MRNA is $24.00. Here's what it takes to justify the current valuation. *The average price target includes all analyst analysis, not just the most recent analysis presented in the chart. * Average Estimates in Million (e.g. Should You Be Worried About AstraZeneca Stock? Disclaimer. These three wildly popular stocks are making investors rich. The firm has opened its preliminary data to regulators in Britain and will allow a "rolling review" of the developments. Pfizer is another significant rival which is aiming to announce results as soon as possible. 6:59am / Zacks.com - Paid Partner Content, Oct 30 / Zacks.com - Paid Partner Content, Nov 01 / MotleyFool.com - Paid Partner Content, Oct 31 / MotleyFool.com - Paid Partner Content, Oct 30 / MotleyFool.com - Paid Partner Content, Oct 29 / MotleyFool.com - Paid Partner Content, Moderna (MRNA) Q3 Earnings Lag Estimates, Pipeline Advances, Vertex (VRTX) Beats on Q3 Earnings & Sales, Ups Sales View, 3 Things About Coronavirus Vaccines That You Almost Certainly Won't Like, Forget Moderna -- This Is A More Lucrative Coronavirus Stock, 3 Reasons to Buy Moderna and 1 Reason to Sell, These 2 Robinhood Favorites Could Double by 2022, Moderna INC (MRNA) Q3 2020 Earnings Call Transcript. The use of this website constitutes acceptance of our user agreement. The coronavirus vaccine race remains wide open. The biotech's COVID-19 vaccine development efforts took an important step forward. Moderna shares got a boost as the company continued its COVID-19 vaccine trials. Moderna, Inc. quote is equal to 70.480 USD at 2020-10-26. Copyright 2019© FactSet Research Systems Inc. All rights reserved. Sources: FactSet, Dow Jones, Stock Movers: Gainers, decliners and most actives market activity tables are a combination of NYSE, Nasdaq, NYSE American and NYSE Arca listings. Encouraging news coming out of the biotech regarding its coronavirus vaccine candidate caused its stock to pop. Its product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics. Moderna’s COVID-19 vaccine trial results are key to the stock’s performance. Discover historical prices for MRNA stock on Yahoo Finance. Is Moderna Stock a Buy at This Price? Moreover, there may be a need for more than one immunization amid production and distribution bottlenecks. Keep America Great or Build Back Better? Investors were trying to find their footing with the stock after a series of updates. Results from a small clinical trial involving elderly patients cheered investors. Other advanced projects come from Johnson&Johnson, Novavax, and Inovio. Note: All information on this page is subject to change. Stock quotes by finanzen.net. Based on our forecasts, a long-term increase is expected, the "MRNA" stock price prognosis for 2025-10-15 is 171.608 USD. All times are ET. MRNA will report Q4 earnings on 03/10/2021, News Corp is a network of leading companies in the worlds of diversified media, news, education, and information services. Source: Kantar Media. Fundamental company data and analyst estimates provided by FactSet. The Massachusets-based firm is busy with its Phase 3 test of a COVID-19 vaccine and hopes to publish results as early as November. You should do your own thorough research before making any investment decisions. MRNA earnings call for the period ending March 31, 2019. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. 10 stocks we like better than Moderna When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. FactSet (a) does not make any express or implied warranties of any kind regarding the data, including, without limitation, any warranty of merchantability or fitness for a particular purpose or use; and (b) shall not be liable for any errors, incompleteness, interruption or delay, action taken in reliance on any data, or for any damages resulting therefrom. Change value during other periods is calculated as the difference between the last trade and the most recent settle. Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. All rights reserved. Subscribe to Premium to view Fair Value for MRNA. FXStreet will not accept liability for any loss or damage, including without limitation to, any loss of profit, which may arise directly or indirectly from use of or reliance on such information. The stock price rose more than 12% to roughly $84.50 per share on Wednesday morning. Find real-time MRNA - Moderna Inc stock quotes, company profile, news and forecasts from CNN Business. Your current $100 investment may be … See you at the top! Moderna stock soared to record highs on Monday, minting new fortunes for a small group of executives and scientists.. Most stock quote data provided by BATS. Opinions expressed at FXStreet are those of the individual authors and do not necessarily represent the opinion of FXStreet or its management. A Warner Media Company. Source: FactSet, Indexes: Index quotes may be real-time or delayed as per exchange requirements; refer to time stamps for information on any delays. Moderna Inc (NASDAQ: MRNA) is at the forefront of the global fight against coronavirus. Is Moderna’s Huge IPO in 2018 Worth the Hype? They all hinge on the biotech's COVID-19 vaccine candidate. Moderna's share price fell 10% to $71.67 on Tuesday after health website STAT reported that vaccine experts concluded the company did not release enough information to … The coronavirus vaccine maker is being investigated for failing to disclose government funding in its patent applications. CNN Sans™ & © 2016 Cable News Network. Data are provided 'as is' for informational purposes only and are not intended for trading purposes. Sources: FactSet, Dow Jones, Bonds: Bond quotes are updated in real-time. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2019 and/or its affiliates. All rights reserved. View daily, weekly or monthly format back to when Moderna, Inc. stock was issued. Moderna was one of the first pharma firms to delve into the ambitious project and has also been able to raise funds for these efforts. Here’s what you should know about the public offering of this biotech unicorn this year. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. MRNA earnings call for the period ending March 31, 2020. This company is already generating revenue from its coronavirus projects. Brexit talks continue and there are reports of progress around fisheries. Moderna (NASDAQ:MRNA) Price Target and Consensus Rating 17 Wall Street analysts have issued ratings and price targets for Moderna in the last 12 months. It is set to rise by 1.5% to $68.52 according to pre-market trading data. This NYC Startup Raises $51M to Disrupt the Retirement Industry, The Worst Way to Withdraw From Your Retirement Accounts, 7 Mistakes That Will Ruin Your Retirement Income, 7 Retirement Secrets Smart Americans Should Know, You Can Still Buy This "Millionaire Maker" Stock, Bitcoin Up 30,000X -- Here's Your Backdoor In, This Stock Could Be Like Buying Amazon for $3.19. Standard & Poor's and S&P are registered trademarks of Standard & Poor's Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. Currency in USD, Trade prices are not sourced from all markets, How He Made $2.8M Trading Stocks Part-Time At Home. Multiple daily strategies running 24/7 and FX expert guidance. Shareholder percentage totals can add to more than 100% because some holders are included in the free float. Moderna's stock was trading at $23.61 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Before deciding to trade foreign exchange you should carefully consider your investment objectives, level of experience and risk appetite. Kyle Dennis took a leap of faith and decided to invest his savings of $15K in the stock market — $2.8M later, he owes his success to these strategies. In her scenarios, the vaccine news could move the shares within a $9 range. With a 5-year investment, the revenue is expected to be around +143.48%. Europe is experiencing a severe second wave of coronavirus cases, triggering lockdown announcements in France, Germany – and now the UK. MRNA earnings call for the period ending September 30, 2019. Should you? Major new developments in the race for a COVID-19 vaccine are driving investors to reevaluate their positions. Administering millions of vaccines could raise other issues with competitive immunizations, leaving Moderna with from to rise even if it fails to reach the finish line first. A shocking announcement out of Russia sent shares of companies working on COVID-19 vaccines and treatments sharply lower. See 2020 Elections: Three states traders should watch, plus places that could provide surprises. FXStreet has not verified the accuracy or basis-in-fact of any claim or statement made by any independent author: errors and Omissions may occur.Any opinions, news, research, analyses, prices or other information contained on this website, by FXStreet, its employees, partners or contributors, is provided as general market commentary and does not constitute investment advice.